These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9809194)

  • 1. Natriuresis and inhibition of Na+/K(+)-ATPase: modulation of response by physiological manipulation.
    McDougall JG; Yates NA
    Clin Exp Pharmacol Physiol Suppl; 1998 Nov; 25():S57-60. PubMed ID: 9809194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaliuretic peptide: the most potent inhibitor of Na(+)-K+ ATPase of the atrial natriuretic peptides.
    Chiou S; Vesely DL
    Endocrinology; 1995 May; 136(5):2033-9. PubMed ID: 7720651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ouabain-Sensitive alpha1 Na,K-ATPase enhances natriuretic response to saline load.
    Loreaux EL; Kaul B; Lorenz JN; Lingrel JB
    J Am Soc Nephrol; 2008 Oct; 19(10):1947-54. PubMed ID: 18667729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of volume expansion on the natriuretic response to ouabain infusion.
    Yates NA; McDougall JG
    Ren Physiol Biochem; 1995; 18(6):311-20. PubMed ID: 8711269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blunted natriuretic response to human urine extracts with Na+,K(+)-ATPase inhibiting activity in experimental cirrhosis.
    Asbert M; Clària J; Jiménez W; Arroyo V; Ros J; Gaya J; Rivera F; Rodés J
    J Hepatol; 1994 May; 20(5):660-5. PubMed ID: 8071545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endogenous natriuretic and ouabain-like factors. Their potential role in volume and blood pressure regulation].
    Kramer HJ; Bäcker A; Krampitz G; Meyer-Lehnert H; Michel H
    Klin Wochenschr; 1990 Nov; 68(22):1112-8. PubMed ID: 2177810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natriuretic hormone - a circulating inhibitor of sodium- and potassium-activated adenosine triphosphatase. Its potential role in body fluid and blood pressure regulation.
    Kramer HJ
    Klin Wochenschr; 1981 Nov; 59(22):1225-30. PubMed ID: 6273645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of Na+-K+ ATPase activity on blood pressure regulation and sodium metabolism in DOCA-treated rats].
    Shigetomi S; Tosaki H; Ueno S; Kohno H; Mori K; Katoh K; Tanaka K; Haga H; Kin S; Matsunaga A
    Nihon Naibunpi Gakkai Zasshi; 1989 Oct; 65(10):1198-207. PubMed ID: 2556303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of direct renal arterial infusion of bufalin and ouabain in conscious sheep.
    Yates NA; McDougall JG
    Br J Pharmacol; 1993 Mar; 108(3):627-30. PubMed ID: 8385530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethyl sulfoxide inhibits renal Na(+)-K(+)-ATPase at a site different from ouabain and atrial peptides.
    Chiou S; Vesely DL
    Life Sci; 1995; 57(10):945-55. PubMed ID: 7643719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous Na,K pump ligands are differentially regulated during acute NaCl loading of Dahl rats.
    Fedorova OV; Lakatta EG; Bagrov AY
    Circulation; 2000 Dec; 102(24):3009-14. PubMed ID: 11113054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytochemical demonstration of an endogenous inhibitor of Na-K ATPase and its relationship to familial arterial hypertension].
    de Wardener H
    Nephrologie; 1987; 8(1):3-6. PubMed ID: 3035398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous natriuretic and ouabain-like factors. Their roles in body fluid volume and blood pressure regulation.
    Kramer HJ; Meyer-Lehnert H; Michel H; Predel HG
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):81-9. PubMed ID: 1848764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Na+-K+-ATPase inhibitors and renin release: relationship to calcium.
    Cruz-Soto M; Benabe JE; López-Novoa JM; Martínez-Maldonado M
    Am J Physiol; 1984 Oct; 247(4 Pt 2):F650-5. PubMed ID: 6093556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic sodium-potassium-ATPase inhibition with ouabain impairs renal haemodynamics and pressure natriuresis in the rat.
    Kurashina T; Kirchner KA; Granger JP; Patel AR
    Clin Sci (Lond); 1996 Oct; 91(4):497-502. PubMed ID: 8983876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of renal Na+,K(+)-ATPase in the regulation of sodium excretion under normal conditions and in acute congestive heart failure.
    Lloyd MA; Sandberg SM; Edwards BS
    Circulation; 1992 May; 85(5):1912-7. PubMed ID: 1315222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Franz Volhard Lecture 1996. Sodium transport inhibitors and hypertension.
    de Wardener HE
    J Hypertens Suppl; 1996 Dec; 14(5):S9-18. PubMed ID: 9120690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of three sodium-potassium adenosine triphosphatase inhibitors.
    Pamnani MB; Chen S; Bryant HJ; Schooley JF; Eliades DC; Yuan CM; Haddy FJ
    Hypertension; 1991 Sep; 18(3):316-24. PubMed ID: 1653768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leptin administered intraperitoneally stimulates natriuresis and decreases renal medullary Na+, K+-ATPase activity in the rat -- impaired effect in dietary-induced obesity.
    Bełtowski J; W jcicka G; Górny D; Marciniak A
    Med Sci Monit; 2002 Jun; 8(6):BR221-9. PubMed ID: 12070427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.